Elevated serum ceruloplasmin levels are associated with albuminuria in Korean men with type 2 diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 94, Issue 1, 2011, Pages

  Jung, Chang Hee ^a   Lee, Woo Je ^a   Yu, Ji Hee ^a   Hwang, Jenny Yoonoo ^a   Shin, Mi Seon ^a   Koh, Eun Hee ^a   Kim, Min Seon ^a   Park, Joong Yeol ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Albuminuria; Ceruloplasmin; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

CERULOPLASMIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK FACTOR;

AGED; ALBUMINURIA; CERULOPLASMIN; DIABETES MELLITUS, TYPE 2; HUMANS; KOREA; MALE; MIDDLE AGED;

EID: 80054946421     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.06.019     Document Type: Article

References (17)

1. Maritim A.C., Sanders R.A., Watkins J...B. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003, 17:24-38.
2. Fox P.L, Mukhopadhyay C., Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci 1995, 56:1749-1758.
3. Ryden L., Eaker D. Identification of the thiol groups in human ceruloplasmin. Eur J Biochem 1983, 132:241-247.
4. Frieden E. Perspectives on copper biochemistry. Clin Physiol Biochem 1986, 4:11-19.
5. 2+, ceruloplasmin, and phosphate. Arch Biochem Biophys 1992, 295:302-308.
6. Atanasiu R.L., Stea D., Mateescu M.A., Vergely C., Dalloz F., Briot F., et al. Direct evidence of caeruloplasmin antioxidant properties. Mol Cell Biochem 1998, 189:127-135.
7. Roeser H.P., Lee G.R., Nacht S., Cartwright G.E. The role of ceruloplasmin in iron metabolism. J Clin Invest 1970, 49:2408-2417.
8. Jones A.F., Winkles J.W., Jennings P.E., Florkowski C.M., Lunec J., Barnett A.H. Serum antioxidant activity in diabetes mellitus. Diabetes Res 1988, 7:89-92.
9. Memisogullari R., Bakan E. Levels of ceruloplasmin, transferrin, and lipid peroxidation in the serum of patients with Type 2 diabetes mellitus. J Diabetes Complications 2004, 18:193-197.
10. Mohora M., Virgolici B., Coman A., Muscurel C., Gaman L., Gruia V., et al. Diabetic foot patients with and without retinopathy and plasma oxidative stress. Rom J Intern Med 2007, 45:51-57.
11. Nowak M., Wielkoszynski T., Marek B., Kos-Kudla B., Swietochowska E., Sieminska L., et al. Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clin Exp Med 2010, 10:185-192.
12. Ehrenwald E., Chisolm G.M., Fox P.L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 1994, 93:1493-1501.
13. Lee H.S., Song C.Y. Oxidized low-density lipoprotein and oxidative stress in the development of glomerulosclerosis. Am J Nephrol 2009, 29:62-70.
14. Verges B. Anomalies of lipid metabolism in diabetes mellitus. Rev Med Interne 1991, 12:277-281.
15. Cunningham J., Leffell M., Mearkle P., Harmatz P. Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complication. Metabolism 1995, 44:996-999.
16. Yamazaki M., Ito S., Usami A., Tani N., Hanyu O., Nakagawa O., et al. Urinary excretion rate of ceruloplasmin in non-insulin-dependent diabetic patients with different stages of nephropathy. Eur J Endocrinol 1995, 132:681-687.
17. Milne D.B. Assessment of copper nutritional status. Clin Chem 1994, 40:1479-1484.